查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1824524

2025年滥用药物（DOA）检测全球市场报告

Drugs of Abuse (DOA) Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年药物滥用 (DOA) 检测市场将强劲成长，到 2029 年将达到 112.1 亿美元，年复合成长率（CAGR）为 8.9%。预测期内的增长可归因于体育运动检测的扩大、意识和教育的增强、毒品犯罪的增加、企业健康计划的实施以及检测方法的进步。预测期内的主要趋势包括可携式和手持式检测设备的使用、实验室资讯管理系统 (LIMS) 的采用、对合成药物检测的关注、大麻检测需求的不断增长以及人工智慧 (AI) 在结果解读中的应用。

未来五年8.9%的成长率预测比我们先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。征收关税可能会增加从德国和韩国进口的质谱试剂和免疫检测分析仪的成本，从而降低常规筛检能力，并损害职场安全专案。互惠关税以及不断升级的贸易紧张局势和限制措施对全球经济和贸易的负面影响可能会更加广泛。

药物滥用治疗需求的不断增长预计将推动药物滥用 (DOA) 检测市场的成长。药物滥用（物质滥用）涉及使用对自己或他人有害的剂量的物质。药物检测有助于透过初步筛检测试识别这些物质，然后进行确认测试以检测和检验特定化合物的存在。随着药物滥用治疗需求的增加，对 DOA 检测的需求也增加。例如，2023 年 12 月，英国英国平台 GOV.UK 报告称，2022 年 4 月至 2023 年 3 月期间，有 290,635 名成年人获得了药物和酒精服务，比前一年的 289,215 人略有增加。治疗入院人数也有所增加，与上年度的130,490 人和 133,704 人相比，入院人数为 137,749 人。因此，对药物滥用治疗的需求不断增长正在推动 DOA 检测市场的扩张。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章 - 市场 - 宏观经济情境宏观经济情境包括利率、通货膨胀、地缘政治、贸易战和关税，以及 COVID-19 大流行和復苏对市场的影响。

第五章 全球成长分析与策略分析框架

  • 全球滥用药物 (DOA) 测试：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球药物滥用（DOA）检测市场：成长率分析
  • 全球滥用药物 (DOA) 检测市场表现：规模与成长，2019-2024 年
  • 全球药物滥用 (DOA) 检测市场预测：规模与成长，2024-2029 年，2034 年
  • 全球滥用药物 (DOA) 检测：总潜在市场 (TAM)

第六章 市场细分

  • 全球滥用药物 (DOA) 检测市场（按产品和服务划分）现状及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 分析器
  • 快速检测装置
  • 耗材
  • 化验服务
  • 全球滥用药物 (DOA) 检测市场（按样本类型、实际及预测），2019-2024 年、2024-2029 年、2034 年
  • 尿
  • 头髮
  • 口腔液体
  • 呼吸
  • 全球滥用药物 (DOA) 检测市场：按应用、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 疼痛管理
  • 刑事司法
  • 职场筛检
  • 全球滥用药物 (DOA) 检测市场（按最终用户、实际和预测）2019-2024 年、2024-2029 年、2034 年
  • 医院
  • 诊断实验室
  • 法医学研究所
  • 其他最终用户
  • 全球滥用药物 (DOA) 检测市场：按分析仪 (类型) 细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 免疫检测分析仪
  • 基于层析法的分析仪器
  • 质谱仪系统
  • 全球滥用药物 (DOA) 检测市场：按快速检测设备细分（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 尿液检查套件
  • 唾液检测套组
  • 头髮检测套组
  • 全球滥用药物 (DOA) 检测市场：按消耗品（类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 测试条
  • 试剂
  • 采样装置
  • 全球滥用药物 (DOA) 检测市场：按检测服务类型、绩效和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 毒性测试
  • 确认测试
  • 筛检服务

第七章 区域和国家分析

  • 全球药物滥用 (DOA) 检测市场：区域分析、预测和成长，2019-2024 年、2024-2029 年、2034 年
  • 全球滥用药物 (DOA) 检测市场：按国家、实际结果和预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 药物滥用（DOA）检测市场：竞争格局
  • 药物滥用（DOA）检测市场：公司简介
    • Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Inc.
  • bioMerieux Inc.
  • Dragerwerk AG & Co. KGaA
  • Aegis Sciences Corporation
  • NMS Labs
  • Clinical Reference Laboratory Inc.
  • Cordant Health Solutions
  • Millennium Health
  • ACM Global Laboratories
  • Psychemedics Corporation
  • Alfa Scientific Designs Inc.
  • Alere Toxicology Services
  • Omega Laboratories Inc.
  • BioTek Laboratories

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年药物滥用 (DOA) 检测市场：提供新机会的国家
  • 2029 年滥用药物 (DOA) 检测市场：细分市场带来新机会
  • 2029年药物滥用（DOA）检测市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r26384u

Drug of abuse (DOA) testing involves examining substances, such as drugs, chemicals, or plant products, typically used recreationally. This includes marijuana, cocaine, opioids, amphetamines, alcohol, and PCP, which are screened for on a drug panel. Clinical screening methods use the patient's urine, saliva, blood, hair, or sweat for this purpose.

Drug of Abuse (DOA) testing encompasses various products and services, including analyzers, rapid testing devices, consumables, and laboratory services. Analyzers, automatic devices measuring chemical concentrations, play a crucial role in this domain. The testing involves sample types such as urine, hair, oral fluid, and breath, with applications in pain management, criminal justice, and workplace screening. End-users of DOA testing include hospitals, diagnostic laboratories, forensic laboratories, and other relevant entities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The drugs of abuse (DOA) testing market research report is one of a series of new reports from. The Business Research Company that provides drugs of abuse (DOA) testing market statistics, including drugs of abuse (DOA) testing industry global market size, regional shares, competitors with a drugs of abuse (DOA) testing market share, detailed drugs of abuse (DOA) testing market segments, market trends and opportunities, and any further data you may need to thrive in the drugs of abuse (DOA) testing industry. This drug of abuse (DOA) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drugs of abuse (doa) testing market size has grown strongly in recent years. It will grow from $7.3 billion in 2024 to $7.97 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to government regulations and workplace policies, pre-employment screening, law enforcement and legal procedures, drug rehabilitation programs, transportation industry compliance.

The drugs of abuse (doa) testing market size is expected to see strong growth in the next few years. It will grow to $11.21 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to expanding sports and athletics testing, increasing awareness and education, rise in drug-related crimes, corporate wellness programs, advancements in testing methods. Major trends in the forecast period include use of portable and handheld testing devices, implementation of laboratory information management systems (LIMS), emphasis on synthetic drug testing, increasing demand for cannabis testing, integration of artificial intelligence (AI) for result interpretation.

The forecast of 8.9% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may compromise workplace safety programs by increasing costs for mass spectrometry reagents and immunoassay analyzers sourced from Germany and South Korea, reducing routine screening capabilities. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising demand for drug abuse treatment is expected to drive the growth of the drugs of abuse (DOA) testing market. Drug abuse, or substance abuse, involves using substances in quantities harmful to the individual or others. Drug testing helps identify these substances through an initial screening test followed by confirmatory testing to detect and validate the presence of specific compounds. As the demand for drug abuse treatment increases, the need for DOA testing also grows. For example, in December 2023, the Government of the United Kingdom (GOV.UK), a UK-based government platform, reported that between April 2022 and March 2023, 290,635 adults accessed drug and alcohol services, up slightly from 289,215 in the previous year. Treatment admissions also increased, with 137,749 individuals admitted compared to 130,490 and 133,704 in the two preceding years. Thus, the growing demand for drug abuse treatment is driving the expansion of the DOA testing market.

The growing demand for hospitals is anticipated to drive the expansion of the drugs of abuse (DOA) testing market. Hospitals, as comprehensive healthcare institutions, play a crucial role in delivering a broad spectrum of medical services, treatment, and care for individuals facing illness or injury. The integration of drugs of abuse (DOA) testing within hospitals facilitates early detection of substance abuse, enabling customized treatment plans, enhancing clinical decision-making, ensuring patient safety, and contributing to public health, workplace safety, and efficient healthcare resource utilization. As of August 2023, there are reported to be 1148 hospitals in the UK, emphasizing the significant role hospitals play in healthcare services. Hence, the increasing demand for hospitals is a key factor propelling the growth of the drugs of abuse (DOA) testing market.

Major players in the drugs of abuse (DOA) testing market are directing their efforts towards developing cutting-edge products, including software-as-a-service (SaaS) platforms, to reinforce their market presence. Software-as-a-Service (SaaS) represents a software distribution model where applications are hosted by a third-party provider and accessed by customers over the internet. A notable example is the introduction of the Addison drug discovery software by Merck KGaA, a US-based science and technology company, in December 2023. This software accelerates drug development and enhances the success rate of novel medications and therapies by integrating computer-aided drug design, machine learning, and generative AI. Addison provides recommendations on optimal methods for synthesizing medications, bridging the gap between virtual molecule design and practical manufacturability. By extracting hidden insights from extensive datasets, the platform increases the likelihood of patients benefiting from innovative treatments.

Key players in the drugs of abuse (DOA) testing market are actively introducing new products, including advanced drug testing, to stay ahead in the market competition. Drug testing involves analyzing biological specimens, such as urine, to identify specific drugs or their metabolites. In December 2022, Omega Laboratories Inc., a US-based company specializing in forensic toxicology and hair testing services, launched urine drugs of abuse testing services. These services are known for their ease of use, rapid effects, and affordability. The laboratory provides accredited urine drug testing services, ensuring high quality and precision in test results. Serving over 6,000 clients worldwide, the organization employs both screening and confirmatory testing in urine drug abuse testing services to ensure the accuracy and reliability of the results.

In June 2024, Premier Biotech Inc., a biotechnology company based in the United States, acquired Desert Tox LLC for an undisclosed sum. This acquisition aims to expand Premier Biotech's portfolio of cost-effective drug misuse screening solutions, enhancing the accessibility and efficiency of its drug testing services. Desert Tox LLC, also based in the United States, specializes in toxicology and drug testing solutions, further strengthening Premier Biotech's capabilities in this sector.

Major companies operating in the drugs of abuse (DOA) testing market include Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., bioMerieux Inc., Dragerwerk AG & Co. KGaA, Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

North America was the largest region in the drugs of abuse (DOA) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drugs of abuse (doa) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drugs of abuse (DOA) testing market includes revenues earned by entities by providing services such as analyzers, rapid testing devices, consumables, and laboratory services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drugs of Abuse (DOA) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drugs of abuse (doa) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drugs of abuse (doa) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The drugs of abuse (doa) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services
  • 2) By Sample Type: Urine; Hair; Oral Fluid; Breath
  • 3) By Application: Pain Management; Criminal Justice; Workplace Screening
  • 4) By End User: Hospitals; Diagnostic Laboratories; Forensic Laboratories; Other End Users
  • Subsegments:
  • 1) By Analyzers: Immunoassay Analyzers; Chromatography-Based Analyzers; Mass Spectrometry Systems
  • 2) By Rapid Testing Devices: Urine Test Kits; Saliva Test Kits; Hair Test Kits
  • 3) By Consumables: Test Strips; Reagents; Sample Collection Devices
  • 4) By Laboratory Services: Toxicology Testing; Confirmation Testing; Screening Services
  • Companies Mentioned: Siemens AG; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Laboratory Corporation of America Holdings; Quest Diagnostics Inc.; bioMerieux Inc.; Dragerwerk AG & Co. KGaA; Aegis Sciences Corporation; NMS Labs; Clinical Reference Laboratory Inc.; Cordant Health Solutions; Millennium Health; ACM Global Laboratories; Psychemedics Corporation; Alfa Scientific Designs Inc.; Alere Toxicology Services; Omega Laboratories Inc.; BioTek Laboratories; Premier Biotech Inc.; Dominion Diagnostics LLC; Randox Toxicology Ltd.; Cansford Laboratories Ltd.; United States Drug Testing Laboratories Inc.; American Bio Medica Corporation; Confirm BioSciences; Immunalysis Corporation; Medtox Diagnostics Inc.; Forensic Fluids Laboratories
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drugs of Abuse (DOA) Testing Market Characteristics

3. Drugs of Abuse (DOA) Testing Market Trends And Strategies

4. Drugs of Abuse (DOA) Testing Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Drugs of Abuse (DOA) Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Drugs of Abuse (DOA) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Drugs of Abuse (DOA) Testing Market Growth Rate Analysis
  • 5.4. Global Drugs of Abuse (DOA) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Drugs of Abuse (DOA) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Drugs of Abuse (DOA) Testing Total Addressable Market (TAM)

6. Drugs of Abuse (DOA) Testing Market Segmentation

  • 6.1. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Analyzers
  • Rapid Testing Devices
  • Consumables
  • Laboratory Services
  • 6.2. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine
  • Hair
  • Oral Fluid
  • Breath
  • 6.3. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pain Management
  • Criminal Justice
  • Workplace Screening
  • 6.4. Global Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Other End Users
  • 6.5. Global Drugs of Abuse (DOA) Testing Market, Sub-Segmentation Of Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Immunoassay Analyzers
  • Chromatography-Based Analyzers
  • Mass Spectrometry Systems
  • 6.6. Global Drugs of Abuse (DOA) Testing Market, Sub-Segmentation Of Rapid Testing Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Urine Test Kits
  • Saliva Test Kits
  • Hair Test Kits
  • 6.7. Global Drugs of Abuse (DOA) Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Test Strips
  • Reagents
  • Sample Collection Devices
  • 6.8. Global Drugs of Abuse (DOA) Testing Market, Sub-Segmentation Of Laboratory Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Toxicology Testing
  • Confirmation Testing
  • Screening Services

7. Drugs of Abuse (DOA) Testing Market Regional And Country Analysis

  • 7.1. Global Drugs of Abuse (DOA) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Drugs of Abuse (DOA) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Drugs of Abuse (DOA) Testing Market

  • 8.1. Asia-Pacific Drugs of Abuse (DOA) Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Drugs of Abuse (DOA) Testing Market

  • 9.1. China Drugs of Abuse (DOA) Testing Market Overview
  • 9.2. China Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Drugs of Abuse (DOA) Testing Market

  • 10.1. India Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Drugs of Abuse (DOA) Testing Market

  • 11.1. Japan Drugs of Abuse (DOA) Testing Market Overview
  • 11.2. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Drugs of Abuse (DOA) Testing Market

  • 12.1. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Drugs of Abuse (DOA) Testing Market

  • 13.1. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Drugs of Abuse (DOA) Testing Market

  • 14.1. South Korea Drugs of Abuse (DOA) Testing Market Overview
  • 14.2. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Drugs of Abuse (DOA) Testing Market

  • 15.1. Western Europe Drugs of Abuse (DOA) Testing Market Overview
  • 15.2. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Drugs of Abuse (DOA) Testing Market

  • 16.1. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Drugs of Abuse (DOA) Testing Market

  • 17.1. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Drugs of Abuse (DOA) Testing Market

  • 18.1. France Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Drugs of Abuse (DOA) Testing Market

  • 19.1. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Drugs of Abuse (DOA) Testing Market

  • 20.1. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Drugs of Abuse (DOA) Testing Market

  • 21.1. Eastern Europe Drugs of Abuse (DOA) Testing Market Overview
  • 21.2. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Drugs of Abuse (DOA) Testing Market

  • 22.1. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Drugs of Abuse (DOA) Testing Market

  • 23.1. North America Drugs of Abuse (DOA) Testing Market Overview
  • 23.2. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Drugs of Abuse (DOA) Testing Market

  • 24.1. USA Drugs of Abuse (DOA) Testing Market Overview
  • 24.2. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Drugs of Abuse (DOA) Testing Market

  • 25.1. Canada Drugs of Abuse (DOA) Testing Market Overview
  • 25.2. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Drugs of Abuse (DOA) Testing Market

  • 26.1. South America Drugs of Abuse (DOA) Testing Market Overview
  • 26.2. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Drugs of Abuse (DOA) Testing Market

  • 27.1. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Drugs of Abuse (DOA) Testing Market

  • 28.1. Middle East Drugs of Abuse (DOA) Testing Market Overview
  • 28.2. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Drugs of Abuse (DOA) Testing Market

  • 29.1. Africa Drugs of Abuse (DOA) Testing Market Overview
  • 29.2. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Drugs of Abuse (DOA) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Drugs of Abuse (DOA) Testing Market Competitive Landscape
  • 30.2. Drugs of Abuse (DOA) Testing Market Company Profiles
    • 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Drugs of Abuse (DOA) Testing Market Other Major And Innovative Companies

  • 31.1. Laboratory Corporation of America Holdings
  • 31.2. Quest Diagnostics Inc.
  • 31.3. bioMerieux Inc.
  • 31.4. Dragerwerk AG & Co. KGaA
  • 31.5. Aegis Sciences Corporation
  • 31.6. NMS Labs
  • 31.7. Clinical Reference Laboratory Inc.
  • 31.8. Cordant Health Solutions
  • 31.9. Millennium Health
  • 31.10. ACM Global Laboratories
  • 31.11. Psychemedics Corporation
  • 31.12. Alfa Scientific Designs Inc.
  • 31.13. Alere Toxicology Services
  • 31.14. Omega Laboratories Inc.
  • 31.15. BioTek Laboratories

32. Global Drugs of Abuse (DOA) Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Drugs of Abuse (DOA) Testing Market

34. Recent Developments In The Drugs of Abuse (DOA) Testing Market

35. Drugs of Abuse (DOA) Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Drugs of Abuse (DOA) Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Drugs of Abuse (DOA) Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Drugs of Abuse (DOA) Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer